TGFB1 and cancer: Indeed, increases in systemic TGFβ contribute to age-related cellular senescence, inflammation, neurodegenerative disorders, and cancer, among other conditions.65 In bone, however, we find that the TGFβ ligand levels and transcriptional markers of TGFβ signaling decline with age.